secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001615219-26-000003
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Salarius shareholders re-elect directors, approve executive compensation, ratify EY as auditor
--------------------------------------------------------------------------------

- Votes for Hanish: 143,525; against: 11,932; abstain: 5,761; broker non-votes: 256,225.
- Votes for McVicar: 143,599; against: 10,058; abstain: 7,561; broker non-votes: 256,225.
- Advisory vote on executive compensation approved: 132,240 for, 22,606 against, 6,372 abstentions; broker non-votes: 256,225.
- Ratification of Ernst & Young LLP as auditor: 401,439 for, 12,132 against, 3,872 abstentions.
- Quorum achieved: 417,443 shares present (39.7% of 1,051,782 outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521926000003/0001615219-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521926000003/flks-20251231.htm
  HTML page:      https://secwatch.observer/filing/0001615219-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer